Company intelligence / Profile preview

Beijing Zhongxi Andriatry

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Beijing Zhongxi Andriatry Pharmaceutical Technology is a China-based pharmaceutical company specializing in the development and commercialization of treatments for male health and urological conditions. The company is best known for its development of sildenafil citrate (generic Viagra) and other related small molecule therapeutics. It focuses on providing high-quality, affordable generic and innovative medications within the domestic Chinese market. Beyond andrology, the company explores indications in cardiovascular health, specifically targeting conditions like pulmonary arterial hypertension.

Therapeutic areas: CardiovascularMen's Health
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Beijing Zhongxi Andriatry.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Zhongxi Andriatry.

Explore the full profile